TETRAPHASE PHARMACEUTICALS INC: cashflow_investing

Value{"amount": -2629000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"}
Period2006-07-08 – 2013-03-31
Statuscurrent
EntityTETRAPHASE PHARMACEUTICALS INC
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001193125-13-216677 · Open the official SEC filing →
Retrieved: 2026-08-19T13:11:17.864451+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001373707/cashflow-investing/2013-03-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/a2e0c344-d09f-4ae6-a5b0-3d8f1abec819

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies